title: End-to-end integrated fully continuous production of recombinant monoclonal antibodies.
authors.affiliation: Late Stage Process Development, Genzyme - A Sanofi Company, 45 New York Ave, Framingham, MA 01701, USA.
authors.forename: Rahul
authors.initials: R
authors.lastname: Godawat
authors.affiliation: Late Stage Process Development, Genzyme - A Sanofi Company, 45 New York Ave, Framingham, MA 01701, USA.
authors.forename: Konstantin
authors.initials: K
authors.lastname: Konstantinov
authors.affiliation: Late Stage Process Development, Genzyme - A Sanofi Company, 45 New York Ave, Framingham, MA 01701, USA.
authors.forename: Mahsa
authors.initials: M
authors.lastname: Rohani
authors.affiliation: Late Stage Process Development, Genzyme - A Sanofi Company, 45 New York Ave, Framingham, MA 01701, USA. Electronic address: Veena.Warikoo@genzyme.com.
authors.forename: Veena
authors.initials: V
authors.lastname: Warikoo
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000096:biosynthesis*; D019149:Bioreactors; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D011994:Recombinant Proteins / Q000096:biosynthesis
chemical_list: D000911:Antibodies, Monoclonal; D011994:Recombinant Proteins
keywords: Capture; Continuous chromatography; End-to-end continuous bioprocessing; Integrated perfusion cell culture; Periodic counter-current chromatography